Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19

Figure 1

Comparison of dynamic changes of SAA (a, b) and CRP (c, d) levels between moderate/severe and critically severe groups and between survivors and nonsurvivors during hospitalisation.

(a)

(b)

(c)

(d)